Stoxx Europe 50
|
5 082,32
|
46,66
|
0,93 %
|
Analysen zu Stoxx Europe 50-Werten
| 30.04.26 | Schneider Electric Buy | UBS AG | |
| 30.04.26 | BNP Paribas Buy | UBS AG | |
| 30.04.26 | ING Group Buy | UBS AG | |
| 30.04.26 | Rolls-Royce Buy | UBS AG | |
| 30.04.26 | BBVA Sector Perform | RBC Capital Markets | |
| 30.04.26 | Unilever Sector Perform | RBC Capital Markets | |
| 30.04.26 | Schneider Electric Outperform | RBC Capital Markets | |
| 30.04.26 | GSK Hold | Deutsche Bank AG | |
| 30.04.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.04.26 | UBS Buy | Deutsche Bank AG | |
| 30.04.26 | Santander Buy | Deutsche Bank AG | |
| 30.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.04.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | BBVA Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | GSK Underweight | Barclays Capital | |
| 30.04.26 | Santander Overweight | Barclays Capital | |
| 30.04.26 | BNP Paribas Equal Weight | Barclays Capital | |
| 30.04.26 | TotalEnergies Overweight | Barclays Capital | |
| 30.04.26 | Unilever Outperform | Bernstein Research | |
| 30.04.26 | UBS Equal Weight | Barclays Capital | |
| 30.04.26 | ING Group Overweight | Barclays Capital | |
| 30.04.26 | BNP Paribas Outperform | RBC Capital Markets | |
| 30.04.26 | GSK Neutral | Goldman Sachs Group Inc. | |
| 29.04.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 29.04.26 | GSK Halten | DZ BANK | |
| 29.04.26 | Airbus Kaufen | DZ BANK | |
| 29.04.26 | TotalEnergies Kaufen | DZ BANK | |
| 29.04.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 29.04.26 | AstraZeneca Kaufen | DZ BANK | |
| 29.04.26 | Iberdrola Market-Perform | Bernstein Research | |
| 29.04.26 | RELX Overweight | Barclays Capital | |
| 29.04.26 | BP Buy | Goldman Sachs Group Inc. | |
| 29.04.26 | Novartis Neutral | UBS AG | |
| 29.04.26 | Unilever Hold | Deutsche Bank AG | |
| 29.04.26 | Air Liquide Buy | Deutsche Bank AG | |
| 29.04.26 | Airbus Buy | Deutsche Bank AG | |
| 29.04.26 | Santander Buy | UBS AG | |
| 29.04.26 | TotalEnergies Buy | UBS AG | |
| 29.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.04.26 | AstraZeneca Overweight | Barclays Capital |